Ryan D. Maynard
2007
In 2007, Ryan D. Maynard earned a total compensation of $1.2M as Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $104,000 |
|---|---|
| Non-Equity Incentive Plan | $104,000 |
| Option Awards | $765,547 |
| Salary | $260,000 |
| Other | $501 |
| Total | $1,234,048 |
Maynard received $765.5K in option awards, accounting for 62% of the total pay in 2007.
Maynard also received $104K in bonus, $104K in non-equity incentive plan, $260K in salary and $501 in other compensation.
Rankings
In 2007, Ryan D. Maynard's compensation ranked 3,495th out of 8,700 executives tracked by ExecPay. In other words, Maynard earned more than 59.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,495 out of 8,700 | 60th |
Division Manufacturing | 1,239 out of 3,314 | 63rd |
Major group Chemicals And Allied Products | 235 out of 746 | 69th |
Industry group Drugs | 128 out of 546 | 77th |
Industry Pharmaceutical Preparations | 96 out of 364 | 74th |
Source: SEC filing on April 12, 2010.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2007.
2007
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2007
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2007
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2007
Elliott Grossbard
Rigel Pharmaceuticals